Turing Pharmaceuticals Receives $90,000,000 Series A Round

  • Feed Type
  • Date
    8/12/2015
  • Company Name
    Turing Pharmaceuticals
  • Mailing Address
    1177 Avenue of the Americas 39th Floor New York, NY 10036 USA
  • Company Description
    Turing is a fully integrated biopharmaceutical company focusing on patients with unmet medical needs. We are dedicated to helping patients, who often have limited or no effective treatment options, by developing and commercializing innovative treatments for serious diseases and conditions across a broad range of therapeutic areas.
  • Website
    http://www.turingpharma.com
  • Transaction Type
    Debt
  • Transaction Amount
    $90,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Investor
  • Venture Investor
    Undisclosed

Trending on Xconomy